Towards a comprehensive model for understanding adaptations' impact: the model for adaptation design and impact (MADI)

Cognitive behavioural therapy for anxiety disorders in children and adolescents

A randomized controlled trial of a bidirectional cultural adaptation of cognitive behavior therapy for children and adolescents with anxiety disorders

Online Support and Intervention (OSI) for child anxiety: a case series within routine clinical practice

Formal Implementation of Cost-Effectiveness Evaluations in Japan: A Unique Health Technology Assessment System

Beyond Adoption: A New Framework for Theorizing and Evaluating Nonadoption, Abandonment, and Challenges to the Scale-Up, Spread, and Sustainability of Health and Care Technologies

Increasing access to evidence-based treatment for child anxiety problems: online parent-led CBT for children identified via schools

Using the framework method for the analysis of qualitative data in multi-disciplinary health research

Cost-effectiveness of implementing a digital psychosocial intervention for patients with psychotic spectrum disorders in low- and middle-income countries in Southeast Europe

Evolving child and adolescent mental health and development programs in Chile

Digitally augmented, parent-led CBT versus treatment as usual for child anxiety problems in child mental health services in England and Northern Ireland

Parent-led cognitive behaviour therapy for child anxiety problems: overcoming challenges to increase access to effective treatment

SPIRIT 2013 statement: defining standard protocol items for clinical trials

Cost-effectiveness thresholds: pros and cons

“An uncertain future” - The impacts of United States and other Government Funding Cuts on Global Mental Health Services

Associations of Infertility With Depressive Symptom Change Across Specific Life Stages (Pregnancy, Postpartum, and Midlife) Among Parous Women

 The experience of infertility among parous women is associated with a greater increase in depressive symptoms between the post-partum period and midlife.

Lancet Report: A multifaceted intervention to improve diagnosis and early management of hospitalised patients with suspected acute brain infections in Brazil, India, and Malawi

Revitalizing Health Care Ethics

Risk of adverse infant outcomes associated with maternal mental health and substance use disorders

This study aimed to evaluate the association of mental health and substance use disorders on the risk of adverse infant outcomes overall and by race/ethnicity and payer. Given the risk of adverse infant outcomes associated with mental health and substance use disorders across racial/ethnic groups and payers, our findings highlight the critical importance of policies and clinical guidelines that support early identification and treatment of a broad spectrum of mental health and substance use disorders throughout the perinatal period.

Neurodevelopmental Outcomes After Late Preterm Antenatal Corticosteroids: The ALPS Follow-Up Study

The Antenatal Late Preterm Steroids (ALPS) trial changed clinical practice in the United States by finding that antenatal betamethasone at 34 to 36 weeks decreased short-term neonatal respiratory morbidity. However, the trial also found increased risk of neonatal hypoglycemia after betamethasone. This follow-up study focused on long-term neurodevelopmental outcomes after late preterm steroids. In this follow-up study of a randomized clinical trial, administration of antenatal corticosteroids to persons at risk of late preterm delivery, originally shown to improve short-term neonatal respiratory outcomes but with an increased rate of hypoglycemia, was not associated with adverse childhood neurodevelopmental outcomes at age 6 years or older.